HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph B Ciolino Selected Research

Joseph B Ciolino Research Topics

Disease

8Glaucoma
10/2023 - 01/2014
8Dry Eye Syndromes (Dry Eye Syndrome)
01/2023 - 07/2009
3Corneal Neovascularization
01/2022 - 01/2013
3Cicatrix (Scar)
09/2021 - 01/2020
3Keratitis
01/2019 - 07/2011
3Infections
12/2018 - 04/2016
3Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2015 - 01/2013
3Pruritus (Itching)
01/2015 - 01/2013
2Blepharitis
02/2024 - 10/2023
2Keratoconus
06/2023 - 09/2019
2Pathologic Dilatation (Ectasia)
06/2023 - 12/2018
2Neoplasms (Cancer)
11/2022 - 09/2022
2Retinoblastoma (Glioblastoma, Retinal)
11/2022 - 09/2022
2Blindness (Hysterical Blindness)
10/2020 - 01/2014
2Inflammation (Inflammations)
10/2020 - 11/2014
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2018 - 01/2016
1Erythema
02/2024
1Ocular Hypertension (Glaucoma, Suspect)
10/2023
1Acanthamoeba Keratitis
12/2022
1Pathologic Processes
05/2022
1Diabetes Mellitus
03/2022
1Macular Edema
01/2022
1Bacterial Infections (Bacterial Infection)
11/2021
1Fibrosis (Cirrhosis)
11/2021
1Eye Diseases (Eye Disease)
05/2021
1Presbyopia
04/2021
1Refractive Errors (Refractive Error)
04/2021
1Myopia
04/2021
1Fuchs' Endothelial Dystrophy
03/2021
1Anterior Uveitis
10/2020
1Uveitis
10/2020
1Telangiectasis (Telangiectasia)
10/2020
1Meibomian Gland Dysfunction
10/2020
1Acute Disease
09/2019
1Corneal Ulcer
12/2018
1Ganglion Cysts (Ganglion)
02/2018
1Chemical Burns (Chemical Burn)
02/2018
1Cataract (Cataracts)
01/2018
1Strabismus (Squint)
01/2018
1Eye Infections
11/2016
1Ulcer
11/2016

Drug/Important Bio-Agent (IBA)

7Ophthalmic Solutions (Eye Drops)IBA
02/2024 - 01/2013
4SteroidsIBA
10/2023 - 10/2020
4SolutionsIBA
01/2023 - 01/2014
3Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2023 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 11/2016
3alcaftadineFDA Link
01/2015 - 01/2013
3AllergensIBA
01/2015 - 01/2013
2lotilanerIBA
02/2024 - 10/2023
2Retinaldehyde (Retinal)IBA
03/2022 - 02/2018
2Latanoprost (Xalatan)FDA Link
01/2022 - 01/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2021 - 01/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
09/2021 - 10/2020
2Fluorescein (Funduscein)FDA LinkGeneric
10/2020 - 01/2019
2Lubricant Eye Drops (Artificial Tears)IBA
01/2017 - 01/2015
2Olopatadine Hydrochloride (Patanol)FDA Link
10/2014 - 01/2013
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
10/2023
1miltefosine (Impavido)IBA
12/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022
1Cell Surface ReceptorsIBA
11/2022
1Caspase 3 (Caspase-3)IBA
11/2022
1Biocompatible Materials (Biomaterials)IBA
09/2022
1ElementsIBA
05/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Ranibizumab (Lucentis)FDA Link
01/2022
1MicellesIBA
01/2022
1Bevacizumab (Avastin)FDA Link
01/2022
1besifloxacinFDA Link
11/2021
1IronIBA
05/2021
1N 30IBA
03/2021
1Thrombospondin 1IBA
01/2021
1Platelet-Derived Growth FactorIBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1LipopolysaccharidesIBA
10/2020
1salicylhydroxamic acid (SHAM)IBA
10/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1GuaifenesinFDA LinkGeneric
01/2019
1Expectorants (Mucolytics)IBA
01/2019
1FluoroquinolonesIBA
12/2018
1Moxifloxacin (Avelox)FDA Link
12/2018
1CytokinesIBA
02/2018
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
01/2018
1Amikacin (A.M.K)FDA LinkGeneric
11/2016
1Polymyxin B (Aerosporin)FDA LinkGeneric
11/2016
1Trimethoprim (Proloprim)FDA LinkGeneric
11/2016
1ArgonIBA
10/2016

Therapy/Procedure

9Contact Lenses
12/2022 - 08/2011
7Therapeutics
02/2024 - 01/2017
3Corneal Transplantation (Keratoplasty)
10/2023 - 03/2021
3Lasers (Laser)
01/2018 - 07/2011
2Penetrating Keratoplasty
06/2023 - 01/2022
2Drug Therapy (Chemotherapy)
11/2022 - 09/2022
2Lenses
04/2021 - 10/2020
1Trephining
06/2023
1Keratectomy
09/2021
1Sutures (Suture)
10/2020
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2019
1Hysterectomy
09/2019
1Corneal Cross-Linking
12/2018
1Telescopes
12/2018